4/7/2022CDMO Asymchem Completes Expansion of  Chinese Manufactuing Facilitie...

4/6/2022Novartis, BeiGene's Tislelizumab Gets EMA Review in Esophageal, Lung C...

4/6/2022AstraZeneca Licenses Harbour BioMed's CLDN18.2xCD3 Bispecific Antibody...

4/6/2022Everest Med Enters into an MOU for Partnership with CR Pharma for its ...

4/6/2022USCC: Chinese Companies Listed on Major U.S. Stock Exchanges

4/6/2022Evolution of Innovative Drug R&D in China (Nature)

4/5/2022The Chinese Supreme People's Court Released New Interpretation on Seve...

4/5/2022Hasten Biopharma Acquires Five Cardiovascular and Metabolism Drugs fro...

4/5/2022Chinese VMS OTC Market Up 8.4% in 2021, Driven by Higher Health Awaren...

4/5/2022Investment into Chinese Biotech Falls Abruptly as U.S. Steps Up Scrut...

4/4/2022U.S. Passes Bill to Curb Supply Reliance on China, with Focus on Ph...

4/3/2022Daiichi Sankyo Disposes Chinese Rights of Cravit Formulations and Loca...

4/3/2022SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet T...

4/3/2022Bloomberg: China Weighs Giving U.S. Full Access to Audits of Most Firm...

4/1/2022CASI Pharma Added to SEC List of Firms Facing Possible U.S. Delisting

4/1/2022CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...

4/1/2022Recent Executive Moves

4/1/2022Cancer Statistics in China and United States 2022: Profiles, Trends an...

4/1/2022More Clouds over Multiple Fronts of Chinese Pharma as Geopolitical Ris...

3/31/2022China's Ministry of Science and Technology Publishes Draft Rules on th...

3/31/2022More JAK Therapies for Atopic Dermatitis Expected in China (PharmaDJ)

3/31/2022NMPA Publishes 2021 Annual Report for Adverse Drug Reaction Monitoring

3/31/2022CDE Solicits Comments on the Inspection Checkpoints of Drug MAHs (Draf...

3/31/2022Financial-related Company News Digest (March 2022)

3/31/2022Drug R&D and Product Registration News Digest March 2022 (5)

3/31/2022Recent Executive Moves

3/30/2022'In the Long-Term Interests': FDA Oncology Chief Defends Rejection of ...

3/30/2022As Lilly, Innovent Hit FDA Rebuff, Another China-made PD-1 Cancer Drug...

3/30/2022Brii Bio Enters Strategic Partnership with Sinopharm to Advance Commer...

3/30/2022Biosion Licenses BSI-060T (Anti-Siglec-15) to Pyxis Oncology

Page:145/775 Total number of articles:23233: [First][<<] [143] [144] [145] [146] [147] [>>] [End]